Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer
N. U. Deshpande, A. Bianchi, H. Amirian, I. De Castro Silva, C. I. Rafie, B. Surnar, K. Rajkumar, I. Ogobuiro, M. Patel, S. Mehra, N. Nagathihalli, N. B. Merchant, S. Dhar, J. Datta
The paper develops CXCR2-homing nanoparticles to specifically target PMN-MDSCs in PDAC, reducing arginase activity and enhancing T-cell activity without causing neutropenia.
bioRxiv · May 25, 2024Cancer Biology